{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-017072","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2025-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.181351+00:00","generated_at":"2026-05-17T04:38:34.473036+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Telomir-1 restores MASPIN and RASSF1A tumor suppressors in prostate cancer models","bullets":["Telomir-1 reversed DNA hypermethylation to reactivate MASPIN and RASSF1A in aggressive prostate cancer models.","MASPIN is a natural defense protein blocking invasion and promoting chemotherapy sensitivity; RASSF1A regulates cell cycle and metastasis suppression.","Dose-dependent reduction in RASSF1A methylation; stronger effect when combined with chemotherapy.","Company continues IND-enabling studies for Telomir-1."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-017072","json":"https://secwatch.observer/filing/0001493152-25-017072.json","markdown":"https://secwatch.observer/filing/0001493152-25-017072.md","text":"https://secwatch.observer/filing/0001493152-25-017072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315225017072/0001493152-25-017072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315225017072/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:38:34.473036+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}